Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||
| Net Income | -5,266 | 37,915 | 2,051 |
| Depreciation Amortization | 21,409 | 5,284 | 4,480 |
| Accounts receivable | -20,465 | -37,491 | -18,193 |
| Accounts payable and accrued liabilities | 28,976 | 28,837 | 22,393 |
| Other Working Capital | -45,216 | -43,012 | -22,261 |
| Other Operating Activity | 3,269 | 35,957 | 27,399 |
| Operating Cash Flow | $-17,293 | $27,490 | $15,869 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -892 | -32,913 | -8,740 |
| PPE Investments | -25,692 | -9,117 | -6,431 |
| Net Acquisitions | -220,662 | -20,662 | N/A |
| Purchase Sale Intangibles | -18,084 | -13,067 | -741 |
| Other Investing Activity | -38,675 | -23,995 | -1,764 |
| Investing Cash Flow | $-285,921 | $-86,687 | $-16,935 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 529 | 427,904 | 3,824 |
| Debt Repayment | -819 | -745 | 0 |
| Common Stock Issued | 1,808 | 662 | 4,420 |
| Other Financing Activity | -5,237 | -11,030 | -1,476 |
| Financing Cash Flow | $-3,719 | $416,791 | $6,768 |
| Exchange Rate Effect | 8,800 | -1,890 | -1,112 |
| Beginning Cash Position | 439,999 | 84,295 | 77,289 |
| End Cash Position | 141,866 | 439,999 | 81,879 |
| Net Cash Flow | $-298,133 | $355,704 | $4,590 |
| Free Cash Flow | |||
| Operating Cash Flow | -17,293 | 27,490 | 15,869 |
| Capital Expenditure | -25,692 | -9,117 | -6,431 |
| Free Cash Flow | -42,985 | 18,373 | 9,438 |